Hypertension Flashcards
ACE-I side effects
- cough (bradykinin sensitizes bronchial epithelium to irritants)
- increase creatinine (2 months)
- decrease renal fxn (GFR)
- sulfhydryl effects (neutropenia, rash)
- Hyperkalemia (1 week)
- Angioedema ( potentiation of bradykinin; hives, tongue/throat swelling)
ACE inhibitors
- bind to angiotensin converting enzyme-increase renin and Ang1, decrease Ang2
- decrease aldosterone
- decrease peripheral arterial resistance and intravascular volume
ARB
- selectively block AT1 receptor -> block vasoconstriction, sympathetic activation, cell growth, Na and fluid retention
- also block pathways independent of RAS
- decreased kinin SE, otherwise similar to ACE-I
Renin Inhibitors
- block rate limiting step of RAAS
- do not use w/ ACE-I or ARB
- SE overlap w/ ACE-I or ARB
Diuretics
-Increase urinary excretion of Na -> venodilation , decrease intravascular volume, decrease BP
Diuretic Side Effects
- volume depletion
- hypotension, orthostasis
- electrolye changes- hypokalemia, hypomagnesemia, hyponatremia, hypercalcemia
- ototoxicity
- metabolic side effects-hyperglycemia, hypercholesterolemia, hyperuricemia
- erectile dysfunction
- sulfa allergy
Aldosterone Antagonist
aldosterone-> increased fluid retention by increased NaCl absorption, direct peripheral vasoconstriction, endothelial dysfunction
Spironolactone
-non-selective aldosterone antagonist
-good for tx in heart failure
-binds to progesterone and androgen receptors
Side effects:
-men-erectile dysfunction, gynecomastia
-women-menstrual abnormalities
Eplerenone
- selective aldosterone antagonist
- similar actions as spironolactone but better SE
Calcium channel blockers
- L type Ca channels-> Ca influx and smooth muscle contraction
- CCB bind receptors -> vasodilation, decrease peripheral vascular resistance
Dihydropyridines (amlodipine)
- CCB
- vascular smooth muscle only (arteriolar dilation)
- SE: edema, HA, flushing, dizziness, palpitation, reflex tachycardia, gingival hyperplasia, aggravate GI reflux
Non-dihydropyridine (diltiazem, verapamil)
- CCB
- vascular smooth muscle and myocardium
- SE: bradycardia, AV block, constipation, gingival hyperplasia, aggravate GI reflux
B-adrenoreceptor blockers
- decrease cardiac output
- inhibit renin secretion
- inhibit NE and Epi release
- decrease HR (decreased automaticity in sinus node)
- decrease myocardial contractility
- reduce ventricular hypertrophy, stroke, heart failure, coronary events, and mortality
- lipid soluble or hydrophilic
- 1st line if CAD, heart failure
- some partial agonists- weak sympathomimetic activity
Selective B-blockers
- B1 only
- myocardium, less effect on airways
- atenolol, metoprolol
Non-Selective B-blockers
- B1 and B2
- myocardium, vascular, and bronchial cells
- may exacerbate asthma, COPD
- carvedilol, propanolol